Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

RAPP - Rapport Therapeutics, Inc. Financial... | Finranks

Home

/

RAPP

R

Rapport Therapeutics, Inc. (RAPP)

NGM – Real Time Price. Currency in USD

48.19

-0.63 (-1.29%)

Market open: Aug 12, 2026, 12:38 PM EDT

49.78

+0.96 (1.97%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

0

0

Cost of goods sold

-1M

-839K

-112K

-15K

Gross Profit

-1M

-839K

-112K

-15K

Operating expenses (excl. COGS)

-124M

-82M

-36M

-10M

Operating Income

-125M

-83M

-36M

-10M

Non-operating income, total

14M

5M

1M

-285K

Pretax income

-111M

-78M

-35M

-11M

Equity in earnings

0

0

0

0

Taxes

0

0

-10K

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-111M

-78M

-35M

-11M

Discontinued operations

0

0

0

0

Net income

-111M

-78M

-35M

-11M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

-

-

Name

2025

2024

2023

2022

Total assets

512M+62.7%

315M+102.6%

155M+391.8%

32M

Total current assets

499M

310M

151M

31M

Total non-current assets

14M

5M

5M

335K

Total liabilities

28M+192.2%

10M-34.3%

14M+19.7%

12M

Total current liabilities

19M

9M

9M

2M

Total non-current liabilities

9M

739K

6M

10M

Total equity

485M

305M

141M

20M

Total liabilities & shareholders' equities

512M

315M

155M

32M

Total debt

11M+678.0%

1M-31.2%

2M

0

Name

2025

2024

2023

2022

Cash from operating activities

-87M

-65M

-27M

-3M

Cash from investing activities

-187M

-170M

-79M

-5M

Cash from financing activities

271M

222M

145M

40M

Free cash flow

-88M-31.0%

-67M-133.3%

-29M-717.3%

-4M